Evidence map›Paper›PMID 31999698›Full record

ArticlePloS one2020

Tryptophan residue 32 in human Cu-Zn superoxide dismutase modulates prion-like propagation and strain selection.

Anthony Crown, Luke McAlary, Eric Fagerli, Hilda Brown, Justin J Yerbury, Ahmad Galaleldeen, Neil R Cashman, David R Borchelt, Jacob I Ayers

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Anthony CrownCenter for Translational Research in Neurodegenerative Disease, SantaFe HealthCare Alzheimer's Disease Research Center, Department of Neuroscience, McKnight Brain Institute, University of Florida, Gainesville, Florida, United States of America.
Luke McAlaryMolecular Horizons and School of Chemistry & Molecular Bioscience, University of Wollongong, New South Wales, Australia.
Eric FagerliCenter for Translational Research in Neurodegenerative Disease, SantaFe HealthCare Alzheimer's Disease Research Center, Department of Neuroscience, McKnight Brain Institute, University of Florida, Gainesville, Florida, United States of America.
Hilda BrownCenter for Translational Research in Neurodegenerative Disease, SantaFe HealthCare Alzheimer's Disease Research Center, Department of Neuroscience, McKnight Brain Institute, University of Florida, Gainesville, Florida, United States of America.
Justin J YerburyMolecular Horizons and School of Chemistry & Molecular Bioscience, University of Wollongong, New South Wales, Australia.
Ahmad GalaleldeenDepartment of Biological Sciences, St. Mary's University, San Antonio, Texas, United States of America.
Neil R CashmanDjavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada.
David R BorcheltCenter for Translational Research in Neurodegenerative Disease, SantaFe HealthCare Alzheimer's Disease Research Center, Department of Neuroscience, McKnight Brain Institute, University of Florida, Gainesville, Florida, United States of America.
Jacob I AyersCenter for Translational Research in Neurodegenerative Disease, SantaFe HealthCare Alzheimer's Disease Research Center, Department of Neuroscience, McKnight Brain Institute, University of Florida, Gainesville, Florida, United States of America.ORCID 0000-0003-4544-2366
University of Florida · USUniversity of Wollongong · AUSt. Mary's University, Texas · USUniversity of British Columbia · CAUniversity of California, San Francisco · US

Funding

Modeling the progression of SOD1-linked motor neuron diseaseR01NS092788 · NINDS · UNIVERSITY OF FLORIDA · PI PARAMITA CHAKRABARTY · 2015 to 2026
$3.6M
Nikon A1R two-photon microscope for a shared resourceS10OD020026 · OD · UNIVERSITY OF FLORIDA · PI KHOSHBOUEI, HABIBEH · 2015 to 2015
$600k
Seeded transmission of SOD1 misfoldingR21NS088839 · NINDS · UNIVERSITY OF FLORIDA · PI BORCHELT, DAVID R · 2015 to 2016
$413k
NIH HHS S10 OD020026NINDS NIH HHS R01 NS092788NINDS NIH HHS R21 NS088839
6 · The paper itself

Abstract

Mutations in Cu/Zn superoxide dismutase 1 (SOD1) associated with familial amyotrophic lateral sclerosis cause the protein to aggregate via a prion-like process in which soluble molecules are recruited to aggregates by conformational templating. These misfolded SOD1 proteins can propagate aggregation-inducing conformations across cellular membranes. Prior studies demonstrated that mutation of a Trp (W) residue at position 32 to Ser (S) suppresses the propagation of misfolded conformations between cells, whereas other studies have shown that mutation of Trp 32 to Phe (F), or Cys 111 to Ser, can act in cis to attenuate aggregation of mutant SOD1. By expressing mutant SOD1 fused with yellow fluorescent protein (YFP), we compared the relative ability of these mutations to modulate the formation of inclusions by ALS-mutant SOD1 (G93A and G85R). Only mutation of Trp 32 to Ser persistently reduced the formation of the amorphous inclusions that form in these cells, consistent with the idea that a Ser at position 32 inhibits templated propagation of aggregation prone conformations. To further test this idea, we produced aggregated fibrils of recombinant SOD1-W32S in vitro and injected them into the spinal cords of newborn mice expressing G85R-SOD1: YFP. The injected mice developed an earlier onset paralysis with a frequency similar to mice injected with WT SOD1 fibrils, generating a strain of misfolded SOD1 that produced highly fibrillar inclusion pathology. These findings suggest that the effect of Trp 32 in modulating the propagation of misfolded SOD1 conformations may be dependent upon the "strain" of the conformer that is propagating.

Indexed as

Amino Acid SubstitutionAmyotrophic Lateral SclerosisAnimalsAnimals, NewbornDisease Models, AnimalFemaleHumansMaleMiceMice, TransgenicMutagenesis, Site-DirectedPrionsProtein Aggregation, PathologicalRecombinant Fusion ProteinsSuperoxide Dismutase-1TryptophanPrionsRecombinant Fusion ProteinsSOD1 protein, humanSuperoxide Dismutase-1Tryptophan

Identifiers

PMID31999698
PMCPMC6991973
OpenAlexW3003506460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.